Skip to main content

hydrocortisone MR (Efmody®)

 

Appraisal in progress

Indication

Status: In progress

Treatment of congenital adrenal hyperplasia (CAH) in adolescents aged 12 years and over and adults.

Medicine details

Medicine name hydrocortisone MR (Efmody®)
Formulation 5 mg, 10 mg, 20 mg modified-release hard capsules
Reference number 3017
Indication

As above

Company Diurnal Limited
BNF chapter Endocrine system
Submission type Full
Status In progress
NMG meeting date 06/07/2022
AWMSG meeting date 14/09/2022
Date of issue TBC
Follow AWTTC: